Afuco™ Anti-Human TDRD3 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-TDRD3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodues binding the Tudor domain-containing protein 3 (TDRD3) can be used to treat breast cancers.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-574CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TDRD3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |